Ci:z Investment led a round also backed by CareNet that advanced the total raised by the spinal disease drug developer to more than $70m.
US-based spinal disease therapy developer DiscGenics has secured $50m in a series C round led by Ci:z Investment, a subsidiary of cosmetics producer Ci:z Holdings, and backed by medical information provider CareNet.
The round included Mitsubishi UFJ Capital, the venture capital arm of financial services firm Mitsubishi UFJ Group, as well as Eagle Fund SP1, Medical Incubator Japan (MIJ) and unnamed company board members and long-term investors.
CareNet, a subsidiary of medical products group Johnson & Johnson, and MIJ both…
